ERC advanced grant to BRIC researcher Kristian Helin
Director and Professor at BRIC, Kristian Helin has received an ERC advanced grant of 2.3 M Euro for his research. The research of Prof. Helin aims to understand the molecular mechanisms leading to cancer, with a focus on epigenetics and stem cells. Prof. Helin has made several key scientific discoveries in this field and is also a co-founder of the biotech company EpiTherapeutics. Read more about research in the Helin research group.